Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Neoplasms 2 Melanoma 2 Lymphoma, B-Cell, Marginal Zone 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 NSCLC 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Leukemia, Myeloid, Chronic-Phase 1 Gynecological Cancers 1 Fibrosis 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 BRAF V600 Colorectal Cancer 1 Anxiety Disorders 1 Adenomatous Polyposis Coli 1

Interventions

Pharmaceutical Preparations 1 Electroporation 1 Electrochemotherapy 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gynecological Cancers × Pharmaceutical Preparations × Clear all

NCT04760327 2024-10-17

GynECT

Institute of Oncology Ljubljana

Phase 2 Recruiting

Gynecological Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡